As of the latest SEC filings, Immunome Inc. (IMNM) is held by 212 institutional funds. The largest fund shareholder is T. Rowe Price Small-Cap Stock Fund, Inc. (OTCFX), holding an estimated $126,074,076.48 in market value, representing 1.56% of its portfolio.
Funds holding Immunome Inc. (IMNM)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IMNM
- CIK:
- 0001472012
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 1.56% | $126,074,076.48 | 5,764,704 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.12% | $98,532,004.46 | 4,507,411 | Feb 28, 2026 | Apr 24, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 1.31% | $88,721,390.54 | 3,867,541 | Apr 30, 2026 | Jun 29, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $69,242,235.21 | 3,166,083 | Mar 31, 2026 | May 28, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 1.57% | $68,173,382.70 | 3,117,210 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.86% | $64,184,119.74 | 2,934,802 | Mar 31, 2026 | May 28, 2026 |
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.17% | $63,694,745.20 | 2,776,580 | Apr 30, 2026 | Jun 26, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.08% | $54,454,922.19 | 2,489,937 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.87% | $46,598,175.04 | 2,131,664 | Feb 28, 2026 | Apr 24, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.33% | $36,426,978.18 | 1,665,614 | Mar 31, 2026 | May 28, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.38% | $35,383,319.91 | 1,617,893 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.12% | $28,761,420.60 | 1,315,710 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.13% | $26,767,504.42 | 1,224,497 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $25,289,921.25 | 1,156,375 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.07% | $23,170,042.32 | 1,010,028 | Apr 30, 2026 | Jun 26, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.15% | $18,244,544.49 | 834,227 | Mar 31, 2026 | May 28, 2026 |
|
PGSGX
JPMorgan Small Cap Growth Fund
|
MF | JPMorgan | 0.82% | $17,810,840.52 | 814,396 | Mar 31, 2026 | May 29, 2026 |
|
PSBMX
SmallCap Fund
|
MF | Independent / Boutique | 0.60% | $12,633,058.00 | 550,700 | Apr 30, 2026 | Jun 25, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $11,834,829.12 | 541,392 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.05% | $11,021,812.00 | 504,200 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.07% | $10,145,947.38 | 464,133 | Feb 28, 2026 | Apr 28, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.01% | $8,831,652.75 | 403,825 | Mar 31, 2026 | May 26, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.16% | $8,063,643.96 | 368,708 | Mar 31, 2026 | May 29, 2026 |
|
DNSMX
Driehaus Small Cap Growth Fund
|
MF | Independent / Boutique | 0.66% | $7,577,911.26 | 346,498 | Mar 31, 2026 | May 27, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.10% | $6,312,993.12 | 288,792 | Feb 27, 2026 | Apr 24, 2026 |
Advertisement (320x50)